Filing Flows › Medicinova (MNOV) › Q2 2026
Medicinova (MNOV) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Medicinova (MNOV) reported revenue of $458K for the second quarter 2026 (Q2 2026), +241% from a year earlier and +145% from the quarter before. Operating margin was -554.3%, net loss $2.3M (504.8% of revenue).
Medicinova, Q2 2026: revenue $458K (+241% year over year), operating margin -554.3%, net loss $2.3M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $458K | +145% | +241% |
| Operating profit | −$2.5M | — | — |
| Net earnings | −$2.3M | — | — |
| Operating cash flow | −$1.9M | — | — |
What changed
Revenue was $458K in Q2 2026, up 241% year over year and up 145% from the previous quarter.
Operating costs exceeded revenue by $2.5M, an operating margin of -554.3%. Total costs fell 20% while revenue rose 241%. The fastest-growing cost line was General & admin (+27%). The quarter ended with a net loss of $2.3M, narrower than the previous quarter's $2.6M loss.
Operating cash flow was −$1.9M. Non-cash charges added back $5K of depreciation and amortization and $177K of share-based compensation. Working capital and other items added $212K.
Questions
What was Medicinova's revenue in the second quarter 2026?
Medicinova (MNOV) reported revenue of $458K for the second quarter 2026 (Q2 2026), +241% from a year earlier and +145% from the quarter before.
Was Medicinova profitable in the second quarter 2026?
Operating loss was $2.5M (-554.3% of revenue) and net loss $2.3M.
Source: Medicinova 10-Q on SEC EDGAR.